Article

The Hexosamine Biosynthetic Pathway alters the cytoskeleton to modulate cell proliferation…

medRxiv · 2024 · Shakya, R.; Suraneni, P.; Zaslavsky, A.; Rahi, A.; Magdongon, C. B.; Gajjela, R.; Mattamana, B. B.; Varma, D.

Key facts

Title The Hexosamine Biosynthetic Pathway alters the cytoskeleton to modulate cell proliferation and migration in metastatic prostate cancer
First author Shakya, R.; Suraneni, P.; Zaslavsky, A.; Rahi, A.; Magdongon, C. B.; Gajjela, R.; Mattamana, B. B.; Varma, D.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.10.14.618283
Devices mentioned K801561
Product codes mentioned KIP, KIT, LXG, NDS, NJT, LCP

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature